6 Oral - Clinical utility of MammaPrint testing in Invasive Lobular Carcinoma: Results from the MINDACT phase III trial.
Saved in:
| Title: | 6 Oral - Clinical utility of MammaPrint testing in Invasive Lobular Carcinoma: Results from the MINDACT phase III trial. |
|---|---|
| Authors: | Metzger, O.1 (AUTHOR), Cardoso, F.2 (AUTHOR), Poncet, C.3 (AUTHOR), Desmedt, C.4 (AUTHOR), Linn, S.5 (AUTHOR), Wesseling, J.6 (AUTHOR), Hilbers, F.7 (AUTHOR), Aalders, K.8 (AUTHOR), Delorenzi, M.9 (AUTHOR), Delaloge, S.10 (AUTHOR), Pierga, J.Y.11 (AUTHOR), Brain, E.12 (AUTHOR), Vrijaldenhoven, S.13 (AUTHOR), Neijenhuis, P.A.14 (AUTHOR), Rutgers, E.15 (AUTHOR), Piccart, M.16 (AUTHOR), van 't Veer, L.17 (AUTHOR), Viale, G.18 (AUTHOR) |
| Source: | European Journal of Cancer. 2020 Supplement 1, Vol. 138, pS5-S6. 2p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
